In a landmark transaction, US pharmaceutical behemoth Merck has secured the acquisition of London-based Verona Pharma for approximately $10 billion, marking a significant milestone in the biotech sector. The deal
In a landmark transaction, US pharmaceutical behemoth Merck has secured the acquisition of London-based Verona Pharma for approximately $10 billion, marking a significant milestone in the biotech sector. The deal






